InvestorsHub Logo
Followers 2775
Posts 77901
Boards Moderated 1
Alias Born 05/10/2007

Re: None

Wednesday, 02/24/2016 2:20:37 PM

Wednesday, February 24, 2016 2:20:37 PM

Post# of 824
Confidential treatment order for exhibit 10.1 from their 10q was just granted. Exhibit 10.1 is the Bayer deal. Looks like the Bayer/Acura deal is still very much alive and moving forward.

ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Accordingly, excluded information from the following exhibit
will not be released to the public for the time period specified:
Exhibit 10.1 through August 3, 2020

Exhibit 10.1

EXECUTION COPY

LICENSE AND DEVELOPMENT AGREEMENT

This License and Development Agreement (“Agreement”) is made and entered into as of this June 5, 2015 (the “Effective Date”) by and between Bayer HealthCare LLC, with offices at 100 Bayer Blvd., Whippany, NJ 07981 (“Bayer”), and Acura Pharmaceuticals, Inc., with offices at 616 N. North Court, Palatine IL 60067 (“Acura”). Bayer and Acura each are referred to herein as a “Party” and collectively as the “Parties.”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACUR News